FDA Inspection 1264741 — Axogen Corporation
The FDA completed an inspection of Axogen Corporation on Mar 6, 2025 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 6, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Tampa, FL (United States)
Additional Details
Sponsor, Contract Research Organization